Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites

BACKGROUND: Substandard medicines, whether the result of intentional manipulation or lack of compliance with good manufacturing practice (GMP) or good distribution practice (GDP), pose a significant potential threat to patient safety. Spontaneous adverse drug reaction reporting systems can contribut...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Saf
Hoofdauteurs: Juhlin, Kristina, Karimi, Ghazaleh, Andér, Maria, Camilli, Sara, Dheda, Mukesh, Har, Tan Siew, Isahak, Rokiah, Lee, Su-Jung, Vaughan, Sarah, Caduff, Pia, Norén, G. Niklas
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2015
Onderwerpen:
Original Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4544545/
https://ncbi.nlm.nih.gov/pubmed/25687792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-015-0271-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items